Position in SVRA
as of Dec 31, 2025
· filed Jan 29, 2026
Position Value
$60,551,129
+$30,873,028 QoQ
Shares Held
10,041,647
+20.8% QoQ
Ownership
4.90%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 9.908942228301791.ToString("F0")%
None 90.09105777169822.ToString("F0")%
Common Shares in SVRA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Dec 31, 2025VANGUARD GROUP INC holds $65,710,756,184 across 450 Biotechnology names. SVRA ranks #105 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
24,105,823 | $10,928,615,912 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
9,075,153 | $7,004,838,343 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
13,553,932 | $5,389,721,058 | |
| 4 | INSM |
INSMED Inc
|
21,076,344 | $3,668,126,907 | |
| 5 | INCY |
Incyte Corp
|
19,911,434 | $1,966,652,333 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
16,719,886 | $1,331,738,919 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
16,440,459 | $1,300,604,709 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
16,862,691 | $1,289,827,232 |
All Filings in SVRA
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2025-12-31 | $60,551,129 | 10,041,647 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $29,678,101 | 8,313,194 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $19,275,072 | 8,453,980 | Shares | Defined | 2025-08-11 | |
| 2025-03-31 | $22,490,312 | 8,119,247 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $25,511,606 | 8,309,970 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $33,682,605 | 7,944,011 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $26,754,193 | 6,638,758 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $30,196,826 | 6,063,620 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $27,800,249 | 5,914,947 | Shares | Defined | 2024-03-11 | |
| 2023-09-30 | $21,790,191 | 5,764,601 | Shares | Sole | 2023-12-18 | |
| 2023-06-30 | $15,896,249 | 4,975,352 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $9,217,011 | 4,726,673 | Shares | Sole | 2023-07-14 | |
| 2022-12-31 | $7,450,188 | 4,806,573 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $7,447,821 | 4,805,046 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $7,304,397 | 4,805,525 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $6,313,182 | 4,819,224 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $6,001,580 | 4,839,986 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $6,199,299 | 4,492,247 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $7,636,818 | 4,492,247 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $7,099,635 | 3,413,287 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $2,022,445 | 1,758,649 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $1,893,259 | 1,736,937 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $4,327,961 | 1,738,138 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $2,917,061 | 1,375,973 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||